Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Bioorg Med Chem Lett ; 24(9): 2090-3, 2014 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-24709560

RESUMO

Menin functions as an oncogenic cofactor of mixed lineage leukaemia (MLL) fusion proteins in leukaemogenesis. The menin-MLL interface is a potential therapeutic target in acute leukaemia cases. In this study, approximately 900 clinical compounds were evaluated and ranked using pharmacophore-based virtual screening, the top 29 hits were further evaluated by biochemical analysis to discover the inhibitors that target the menin-MLL interface. Two aminoglycoside antibiotics, neomycin and tobramycin, were identified as menin-MLL inhibitors with binding affinities of 18.8 and 59.9 µM, respectively. The results of thermal shift assay validated the direct interactions between the two antibiotics and menin. The results of isothermal titration calorimetry showed that the equilibrium dissociation constant between menin and neomycin was approximately 15.6 µM. We also predicted the binding modes of inhibitors at the menin-MLL interface through molecular docking analysis. The results indicated that neomycin and tobramycin competitively occupy the binding site of MLL. This study has shed light on the development of powerful probes and new therapies for MLL-mediated leukaemogenesis.


Assuntos
Antibacterianos/farmacologia , Proteína de Leucina Linfoide-Mieloide/antagonistas & inibidores , Neomicina/farmacologia , Proteínas Proto-Oncogênicas/antagonistas & inibidores , Tobramicina/farmacologia , Antibacterianos/química , Humanos , Leucemia/tratamento farmacológico , Modelos Moleculares , Proteína de Leucina Linfoide-Mieloide/metabolismo , Neomicina/química , Ligação Proteica/efeitos dos fármacos , Mapas de Interação de Proteínas/efeitos dos fármacos , Proteínas Proto-Oncogênicas/metabolismo , Tobramicina/química
2.
J Comput Aided Mol Des ; 27(3): 247-56, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23456591

RESUMO

New Delhi metallo-ß-lactamase-1 (NDM-1) has emerged as a major global threat to human health for its rapid rate of dissemination and ability to make pathogenic microbes resistant to almost all known ß-lactam antibiotics. In addition, effective NDM-1 inhibitors have not been identified to date. In spite of the plethora of structural and kinetic data available, the accurate molecular characteristics of and details on the enzymatic reaction of NDM-1 hydrolyzing ß-lactam antibiotics remain incompletely understood. In this study, a combined computational approach including molecular docking, molecular dynamics simulations and quantum mechanics/molecular mechanics calculations was performed to characterize the catalytic mechanism of meropenem catalyzed by NDM-1. The quantum mechanics/molecular mechanics results indicate that the ionized D124 is beneficial to the cleavage of the C-N bond within the ß-lactam ring. Meanwhile, it is energetically favorable to form an intermediate if no water molecule coordinates to Zn2. Moreover, according to the molecular dynamics results, the conserved residue K211 plays a pivotal role in substrate binding and catalysis, which is quite consistent with previous mutagenesis data. Our study provides detailed insights into the catalytic mechanism of NDM-1 hydrolyzing meropenem ß-lactam antibiotics and offers clues for the discovery of new antibiotics against NDM-1 positive strains in clinical studies.


Assuntos
Antibacterianos/metabolismo , Klebsiella pneumoniae/enzimologia , Tienamicinas/metabolismo , beta-Lactamases/metabolismo , Descoberta de Drogas , Farmacorresistência Bacteriana , Humanos , Hidrólise , Infecções por Klebsiella/microbiologia , Klebsiella pneumoniae/química , Klebsiella pneumoniae/metabolismo , Meropeném , Simulação de Acoplamento Molecular , Simulação de Dinâmica Molecular , beta-Lactamases/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA